Concealed Paxil Suicide Data Released after years under Court Seal
Dr. Peter Breggin’s sealed expert medical report in a Paxil liability case is now in the public domain.
Bill Frist’s most Frequent Corporate Flight Hosts–Pharmaceutical companies
The nation’s most powerful legislators have grown accustomed to riding in plush private coporate jets. How does that affect public policy?
The Drug Pushers by Carl Elliott Atlantic Monthly
A must read article by Carl Elliott, MD, Ph.D in the Atlantic Monthly provides the best insight into how pharmaceutical drug reps operate and the milieu in which today’s physicians practice
AHRP Letter to FDA Commissioner-Themirosal
Our questions Re: Thimerosal are threefold.
Mercury Crimes at CDC
"It’s time for the CDC to come clean with the American public. Its tactics of deception and obfuscation are jeopardizing the credibility of the entire vaccine program, and therefore posing an enormous danger to public health." Robert Kennedy, Jr. See letter to FDA Commissioner.
Fix the Diagnosis, Not the Children
From both sides of the Atlantic, even psychiatrists are acknowledging–the ADHD diagnosis makes no sense.
Marriage of Convenience: Mental Screening–Eli Lilly check $500k
Mental Screening ties to drug companies exposed. Screening for Mental Health (Harvard affiliated) received $500K from Eli Lillly. See: https://ahrp.org/children/mentalscreen/LillyCheck.jpg
TeenScreen hired high powered PR firms whose business is to create promotional campaigns to increase drug sales for its clients.
OHRP Response to AHRP Complaint & AHRP Reply
Did OHRP conduct an investigation of the PolyHeme blood experiment and did OHRP issue a report of its findings?
FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug
“When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease. Last year, she died at the age of 46 from an infection linked to the drug.”
AHRP Files Federal Complaint Re: Non-Consensual “Blood Substitute” Experiment on Trauma Patients
This controversial, commercial experiment is being conducted without informed consent in trauma patients who require blood to survive. PolyHeme is being tested in patients in ambulances and at hospital emergency facilities where these trauma patients are denied life-saving real blood.
UK-MHRA Drug-Related Suicide Reports_Yellow Card
The UK adverse event drug reporting system utilizes the Yellow Card system for filing reports.
Glaxo to Polish Industry Image
AdAge reports: